Get the Stockscreener App
5.099
0.57%
0.029
Cryo Cell International Inc stock is traded at $5.099, with a volume of 7,278.
It is up +0.57% in the last 24 hours and up +2.60% over the past month.
Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, kidney, ALS, wound healing, and auto-immune diseases. The company also manufactures and sells PrepaCyte CB processing system, a technology used to process umbilical cord blood stem cells. It stores approximately 500,000 cord blood and cord tissue stem cells worldwide. The company markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. Cryo-Cell International, Inc. was incorporated in 1989 and is headquartered in Oldsmar, Florida.
See More
Previous Close:
$5.07
Open:
$5.1157
24h Volume:
7,278
Relative Volume:
0.65
Market Cap:
$44.29M
Revenue:
$31.34M
Net Income/Loss:
$-9.52M
P/E Ratio:
-4.7521
EPS:
-1.073
Net Cash Flow:
$1.28M
1W Performance:
+0.57%
1M Performance:
+2.60%
6M Performance:
-30.86%
1Y Performance:
-27.36%
1-Day Range:
$5.0001
$5.1157
1-Week Range:
$5.0001
$6.35
52-Week Range:
$4.75
$9.43
Cryo Cell International Inc Stock (CCEL) Company Profile
Name
Cryo Cell International Inc
Sector
Industry
Phone
813 749 2100
Address
700 Brooker Creek Boulevard, Suite 1800, Oldsmar
Compare CCEL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| 5.10 | 0 | 0 | 0 | 0 | 0.00 | |
MOBBW
Mobilicom Limited Warrants
|
0.3499 | 544.73M | 0 | 0 | 0 | 0.00 |
|
GOODO
Gladstone Commercial Corporation
|
20.57 | 372.90M | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
0.1418 | 316.76M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
SHMD
Schmid Group N V
|
2.79 | 118.42M | 0 | 0 | 0 | 0.00 |
|
DAVEW
Dave Inc
|
2.04 | 0 | 0 | 0 | 0 | 0.00 |
Cryo Cell International Inc Stock (CCEL) Latest News
Global Cell and Tissue Preservation Market Market to Witness - openPR.com
Umbilical Cord Blood Banking Market: Benefits, Costs & Future Uses Till 2031 Says, DataM Intelligence - openPR.com
How to Take Advantage of moves in (CCEL) - news.stocktradersdaily.com
Stem Cell Banking: Investing in the Future of Medicine | Top Companies Investment & Growth Analysis2025 - openPR.com
Stem Cell Banking Market To Witness Substantial Growth, - openPR.com
Cell Banking Outsourcing Market To Witness Substantial Growth, - openPR.com
Northern Trust Corp Grows Position in Cryo-Cell International, Inc. (NYSEAMERICAN:CCEL) - Defense World
Cell Banking Outsourcing Market Grows as Biopharma Focus Shifts - openPR.com
Duke terminates deal with public company that claimed $100M in damages - The Business Journals
Learn to Evaluate (CCEL) using the Charts - news.stocktradersdaily.com
Cryo-Cell Faces License Termination by Duke University - TipRanks
Dry Ice Market Size to worth USD 2.79 Billion by 2032: Amid Expanding Cold Chain Logistics - GlobeNewswire
Stem Cell Banking Market Is Booming So Rapidly 2025-2032Stem - openPR.com
Placental Stem Cell Therapy for Neurological Disorders Market - openPR.com
Stem Cell Banking Market Deep Research with Forecast - openPR.com
Global Biobanking Market Driven by Innovation and Research, Growing at 8% CAGR by 2027 - PharmiWeb.com
Cell Banking Outsourcing Market: Executive Briefing & - openPR.com
Cord Blood Stem Cells Global Market Overview 2025: Rising - GlobeNewswire
Cell Processing Market Deep Research with Forecast By 2025-2032 - openPR.com
Cryo-Cell International Declares Reduced Quarterly Dividend - TipRanks
Cord Blood Banking Leader Cryo-Cell Announces Cash Dividend | CCEL Stock News - GuruFocus
Cord Blood Banking Leader Cryo-Cell Announces Cash Dividend - The Joplin Globe
Stem Cell Banking Market Generated Opportunities, Future Scope - openPR.com
(CCEL) Technical Pivots with Risk Controls - news.stocktradersdaily.com
Cell Regeneration Medicine Market to Reach $90.1 Billion by 2031 - openPR.com
Cell Banking Outsourcing Market Deep Research with Forecast - openPR.com
Cell Processing Market Deep Research Report with Forecast - openPR.com
Press Release Distribution & PR Platform - ACCESS Newswire
Global Automated Cell Biology Systems Market is projected - openPR.com
U.S. Stem Cell Banking Market Business Growth and Industry Development by 2034 - openPR.com
Emerging Trends in Cell Resource Storage Service Market 2025 - openPR.com
New Horizons in Cell Storage Preparation Service Market - openPR.com
U.S. Cell Banking Outsourcing Market New Product Development & - openPR.com
Stem Cell Banking Market Projected To Witness Substantial - openPR.com
Umbilical Cord Blood Banking Market Poised Growth Through 2032, Reports Persistence Market Research - openPR.com
(CCEL) Proactive Strategies - news.stocktradersdaily.com
Cord Blood Banking Services Market Detailed In New Research - openPR.com
Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2025 Financial Results | CCEL Stock News - GuruFocus
Company's Revenue Sees Slight Increase in Q1 2025 | CCEL Stock N - GuruFocus
Company's Revenue Sees Slight Increase in Q1 2025 | CCEL Stock News - GuruFocus
Cryo-Cell International Q1 Revenue USD 7.97 Million - marketscreener.com
Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2025 Financial Results - Business Wire
New Horizons in Baby Stem Cell Storage Market Exploring Future - openPR.com
Latest Research Report on Placental Stem Cell Therapy - openPR.com
CCEL stock touches 52-week low at $5.68 amid market challenges By Investing.com - Investing.com South Africa
CCEL stock touches 52-week low at $5.68 amid market challenges - Investing.com India
Cell Banking Outsourcing Market Deep Research 2025-2032 | Charles River Laboratories, Cryo-Cell International Inc - openPR.com
Cryo Cell International Inc Stock (CCEL) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.44%
Cap:
|
Volume (24h):